In acute myeloid leukemia (AML), a recent study also suggests a tumor-suppressing role of chemerin, demonstrating that chemerin was down-regulated in the bone marrow mononuclear cells of AML patients compared to that of healthy controls. This evidence concerns the gene RARRES2 and acute myeloid leukemia.